Advances in Immunotherapy for Hepatitis B
Hepatitis B virus (HBV) is a hepatotropic virus with the potential to cause chronic infection, and it is one of the common causes of liver disease worldwide. Chronic HBV infection leads to liver cirrhosis and, ultimately, hepatocellular carcinoma (HCC). The persistence of covalently closed circular...
Main Authors: | Dongyao Wang, Binqing Fu, Haiming Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/11/10/1116 |
Similar Items
-
Theranostics Applications of Nanoparticles in Cancer Immunotherapy
by: Yihai Liu, et al.
Published: (2018-11-01) -
Correspondence on editorial regarding “Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction”
by: Mehrangiz Dezhbord, et al.
Published: (2024-10-01) -
Mitochondrial regulation in the tumor microenvironment: targeting mitochondria for immunotherapy
by: Minseo Ahn, et al.
Published: (2024-10-01) -
The Role of Metabolism in Tumor Immune Evasion: Novel Approaches to Improve Immunotherapy
by: Alberto Cruz-Bermúdez, et al.
Published: (2021-03-01) -
New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma
by: Cong Luo, et al.
Published: (2025-01-01)